Evidence map›Paper›PMID 41815279›Full record

ArticleFrontiers in medicine2025

Integrative multi-stage deep learning framework for ovarian tumor ultrasound classification with explainability and confidence estimation.

Shtwai Alsubai, Ahmad Almadhor, Abdullah Al Hejaili

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shtwai AlsubaiCollege of Computer Engineering and Sciences, Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia.
Ahmad AlmadhorDepartment of Computer Engineering and Networks, College of Computer and Information Sciences, Jouf University, Sakaka, Saudi Arabia.
Abdullah Al HejailiComputer Science Department, Faculty of Computers & Information Technology, University of Tabuk, Tabuk, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Ovarian cancer is a major diagnostic problem because it is asymptomatic in its early stages and requires subjective interpretation of ultrasound images. Methods: This research presents the EfficientOvaNet framework, a deep learning-based model for classifying ovarian tumors using ultrasound images, trained on the Multi-Modality Ovarian Tumor Ultrasound (MMOTU) dataset. The framework employs a two-branch EfficientNet-B3 architecture that combines Region-of-Interest (ROI) features with global contextual information. Sophisticated preprocessing, data augmentation, and class-imbalance control using weighted Focal Loss are applied. Five-fold cross-validation is used for performance evaluation. Explainable methods, including Grad-CAM, Monte Carlo Dropout uncertainty estimation, and t-distributed Stochastic Neighbor Embedding (t-SNE)-based feature visualization, are incorporated to ensure interpretability. Results: The five-fold cross-validation yields a mean accuracy of 91.9%, an F1-score of 91.9%, and an AUC of 0.98, indicating better performance than baseline models. Discussion: EfficientOvaNet increases diagnostic accuracy and reduces subjectivity in ultrasound-based ovarian tumor classification. By improving interpretability and credibility, the framework has the potential to support timely intervention and individualized treatment, which may improve survival rates in the management of ovarian cancer.

Indexed as

deep learningEfficientNetexplainable AIMMOTU datasetovarian cancertumor classificationultrasound imaging

Identifiers

PMID41815279
PMCPMC12974135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.